RE:Compelling Reasons to Buy?1. They are a couple of months away from filing a IND with the FDA.
2. Shortly after that, they will begin Phase I trials for their AD drug PMN 310. If the results of said trials show that the drug is effective (and that's a very, very big "if"), the share price will explode and/or they will partner/be bought out by big pharma and we'll all be filthy, stinking rich.
So, roll the dice. Or don't.